Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Isometronidazole-D4

Isometronidazole-D4 is listed in the pharmaceutical impurity collection. Its represented structure has formula C6H9N3O3 and a calculated molecular weight of 175.18 g/mol.

2D chemical structure

2 H 2 H H O 2 H 2 H N N + O O - N

Chemical identity

Catalog name
Isometronidazole-D4
Common name
Isometronidazole-D4
Chemical name
Not available
CAS
Not available
SMILES
[2H]C([2H])(O)C([2H])([2H])n1cc([N+](=O)[O-])nc1C
InChI
InChI=1S/C6H9N3O3/c1-5-7-6(9(11)12)4-8(5)2-3-10/h4,10H,2-3H2,1H3/i2D2,3D2
InChIKey
RSXWJXPKLRYMHW-RRVWJQJTSA-N
Associated API
Metronidazole

Record ID: A1f2d30826fab

Computed properties

C6H9N3O3 Molecular formula
175.1804 g/molMolecular weight
175.0895 DaMonoisotopic exact mass
81.19 ŲTopological polar surface area
0.092 Calculated LogP (Wildman–Crippen)
40.7042 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The structure contains 4 isotopically specified atoms.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 2 4 6 8 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight175.180411.25
Calculated LogP (Wildman–Crippen)0.09214.92
Topological polar surface area81.1958.90
Hydrogen-bond acceptors450.68
Hydrogen-bond donors138.08
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC6H9N3O3dimensionless
Molecular weight175.1804g/mol
Monoisotopic exact mass175.0895Da
Topological polar surface area81.19Ų
Calculated LogP (Wildman–Crippen)0.092dimensionless
Molar refractivity (Wildman–Crippen)40.7042cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors1count
Rotatable bonds (strict)3count
Heavy atoms12count
Heteroatoms6count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.5fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms4count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area74.2321Ų
Valence electrons66count
Radical electrons0count
Bertz complexity425.1435index
Balaban J3.2868index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Isometronidazole-D4

Qualification and safety assessment of Isometronidazole-D4

Explore toxicological qualification of Isometronidazole-D4 and ICH M7 mutagenic impurity assessment of Isometronidazole-D4 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Isometronidazole-D4 and acceptable intake and limit justification for Isometronidazole-D4. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Isometronidazole-D4

Explore Altox services and software through the Altox Pharma-Hub.